Immunoglobulin deficiencies and impaired immune response to polysaccharide antigens in adult patients with recurrent community-acquired pneumonia.
The frequency of humoral immunodeficiencies was analysed in 39 patients with a history of recurrent (> or = 3) episodes of community-acquired pneumonia. Total immunoglobulin levels and/or IgG subclass levels were low in 14 patients (36%), including eight patients with IgG or IgG2 deficiency. The specific antibody activity to pneumococcal capsular polysaccharides (serotypes 3, 6A, 19F, and 23F) and to phosphorylcholine was low in the IgG/IgG2-deficient patients compared to 36 healthy controls, and they also responded poorly to vaccination with a 23-valent pneumococcal capsular polysaccharide vaccine. The remaining 25 patients, with normal immunoglobulin and IgG subclass levels, had specific anti-pneumococcal antibody levels comparable to the healthy controls, and all but 3 responded to vaccination. We conclude that immunoglobulin deficiencies and the inability to respond to polysaccharide antigens are common risk factors for recurrent pneumonia in adult patients. Immunoglobulin levels (including IgG subclasses) and antibody response to polysaccharide antigens should be investigated in these patients.
Ekdahl
K
K
Department of Infectious Diseases, University Hospital of Lund, Sweden.
Braconier
J H
JH
Svanborg
C
C
D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000032:analysis / Q000276:immunology; D000942:Antigens, Bacterial / Q000032:analysis / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology*; D017714:Community-Acquired Infections / Q000276:immunology / Q000517:prevention & control; D004406:Dysgammaglobulinemia / Q000150:complications / Q000453:epidemiology / Q000276:immunology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis / Q000276:immunology*; D007136:Immunoglobulins / Q000032:analysis / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010767:Phosphorylcholine / Q000276:immunology; D022242:Pneumococcal Vaccines; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000276:immunology* / Q000517:prevention & control*; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012008:Recurrence; D012307:Risk Factors; D014611:Vaccination
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D007074:Immunoglobulin G; D007136:Immunoglobulins; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial; D010767:Phosphorylcholine